Arm function and quality of life after trimodal treatment of sulcus superior tumour (SST)

Arm function and quality of life after trimodal treatment of sulcus superior tumour (SST) - Armfunction after treatment for SST

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34727

Enrollment

Registered

2010-04-01

Start date

2010-04-20

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancoast tumour

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Surgical resection of sulcus superior tumour in VUmc after induction treatment with chemoradiatiotherapy Treated after 01-01-2002 Age at treatment between 18 and 80 years

Exclusion criteria

Exclusion criteria: Current functional status ECOG >2 (confined to bed or chair >50% of waking hours) Armfunction not assessable due to causes unrelated to locoregional treatment for SST (e.g. CVA, trauma, brain metastasis)

Design outcomes

Primary

Measure	Time frame
Questionnaire DASH (Disability of Arm, Shoulder and Hand) Questionnaire Quality of life (SF-36) Objective measurement of arm- and shoulderfunction (treated and untreated extremity) A.R.A.-test: Action research arm-test 9-hole peg-test R.O.M.-test: Range Of Motion-test FAT-test: Frenchay Arm Test	—

Secondary

Measure	Time frame
Age Symptomatic period before start treatment Radiotherapy dose chemotherapy scheme clinical tumour stage (cTNM) pathological tumour stage (pTNM) Time interval between induction and surgery Time interval between surgery and study date Right or left handedness	—

Countries

Netherlands

Outcome results